SMN2 and spinal muscular atrophy, type II: For instance, Schwartz et al. reported 21 patients with two SMN2 copies treated within 6 weeks of birth, of which 6 (29%) showed proximal predominant muscle weakness and 3 showed clinical signs of SMA type II–like symptoms at 16–30 months [19].